Michael P. Lisanti, M.D, Ph.D, FRSA, FRSB

Keynote Speaker

Professor and Chair of Translational Medicine, University of Salford, Manchester, United Kingdom

Kenneth A. Jacobson, Ph.D.

Keynote Speaker

Senior Investigator and Chief, Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bethesda, MD

Raphael Mechoulam, Ph.D.

Keynote Speaker

Head, Medicinal Chemistry Lab, President, Multidisciplinary Center for Cannabinoid Research, The Hebrew University of Jerusalem, Israel

Michael S. Wolfe, Ph.D.

Keynote Speaker

Mathias P. Mertes Professor, Department of Medicinal Chemistry, University of Kansas, Lawrence, KS

William Gerwick, M.D.

Keynote Speaker

Distinguished Professor of Oceanography and Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California at San Diego, La Jolla, CA

Barbara Slusher, Ph.D., MAS

Keynote Speaker

Director, Johns Hopkins Drug Discovery Program, Johns Hopkins University, Baltimore, MD

Philip S. Low, Ph.D.

Keynote Speaker

Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry, Purdue University, West Lafayette, IN

Kattesh V. Katti, M.Sc.Ed, Ph.D., DSC, FRSC, FNAI

Keynote Speaker

Professor of Radiology, Director, Institute of Green Nanotechnology, University of Missouri, Columbia, MO

Petr Kuzmic, Ph.D.

Keynote Speaker

President & CEO, BioKin Ltd., Watertown, MA

David Light, Ph.D.

Featured Speaker

Founder & CEO,
Valisure, New Haven, CT

Mark T. Hamann, Ph.D.

Keynote Speaker

Charles and Carol Cooper/State Endowed Chair, Professor of Drug Discovery, Biomedical Sciences and Public Health, Medical University of South Carolina, Charleston, SC

Brian S. J. Blagg, Ph.D.

Featured Speaker

Director, the Warren Family Center for Drug Discovery and Development, The University of Notre Dame, Notre Dame, IN

Jonathan B. Baell, Ph.D.

Featured Speaker

NHMRC Principal Research Fellow, Director, Australian Translational Medicinal Chemistry Facility, Larkins Fellow, Department of Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Australia

Shuji Ogino, MD, PhD, MS

Advisory Board

Chief of Molecular Pathological Epidemiology (MPE) Program, Professor (Epidemiology),
Harvard Medical School,
Longwood Ave. Boston

Michelle Arkin, PhD

Featured Speaker

Co-director, Small Molecule Discovery Center (SMDC), Professor, Pharmaceutical Chemistry, University of California San Francisco, CA

Paul A. Insel, MD

Featured Speaker

Distinguished Professor of Pharmacology & Medicine, Co-Director, Medical Scientist (MD/PhD) Training Program, University of California San Diego, CA

Adam Renslo, MD, PhD, MS

Featured Speaker

Professor of Pharmaceutical Chemistry, Co-Director, Small Molecule Discovery Center, University of California, CA

Phillip M. Gerk, Pharm.D., Ph.D.

Advisory Board

Associate Professor, Dept. of Pharmaceutics, Virginia Commonwealth University,
Richmond, VA

James M. Cook, FRSC

Featured Speaker

University Distinguished Professor, Department of Chemistry & Biochemistry, University of Wisconsin Milwaukee, WI

Howard I. Maibach, M.D.

Advisory Board

Professor, Department of Dermatology, University of California,
San Francisco, CA

Yan Zhang, Ph.D.

Advisory Board

Professor of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA